# Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy

> **NCT07410169** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Breast Cancer
- CIPN - Chemotherapy-Induced Peripheral Neuropathy
- Paclitaxel-induced Peripheral Neuropathy

## Interventions

- **DEVICE:** Hyperbaric oxygen treatment
- **OTHER:** Standard Care (in control arm)

## Key facts

- **NCT ID:** NCT07410169
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-31
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07410169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07410169, "Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07410169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*